The Australian Clinical Pharmacy Award for 2015 has been awarded to Dr Christine Carrington at Medicines Management 2015, the SHPA National Conference.
The Australian Clinical Pharmacy Award is one of SHPA’s highest honours and is bestowed to recognise outstanding contributions to clinical pharmacy practice.
Christine has many years of experience as a clinical pharmacist in cancer services and is currently the Assistant Director of Pharmacy and Senior Consultant Pharmacist, Cancer Services at the Princess Alexandra Hospital in Brisbane.
Dr Carrington is a leader in cancer pharmacy at a local, state and national level and is frequently called upon to provide high level consultant advice, says SHPA.
She chaired the Clinical Oncology Society of Australia (COSA) working group that wrote the Guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy which have become an everyday part of clinical practice.
She supports pharmacists in Queensland to manage complex cancer medication cases through the cancer pharmacists mentoring program. She is a member and former chair of the COSA Cancer Pharmacists Group and is an elected member of the Board of COSA.
Dr Carrington is highly engaged in cancer care across all healthcare disciplines and shares her expertise through her membership of many committees and groups, chairing a number of them, SHPA says.
Dr Carrington has been instrumental in helping patients access new medicines, driving the standardisation of chemotherapy pathways and rolling out the statewide oncology prescribing and medicines management system.
Dr Carrington’s experience as an educator is extensive; she mentors pharmacy students and pharmacists, supervises higher degree students, and delivers education in her workplace, at the University of Queensland and through involvement in SHPA, COSA, and the International Society of Oncology Pharmacy Practitioners.
She founded the national course Clinical skills for cancer pharmacy practitioners and developed, evaluated and implemented a competency framework for cancer pharmacists.
She has developed and led the implementation of the education program for advanced trainee medical staff on the Pharmacology of cancer chemotherapy. The program has recently been rolled out across three states.
Dr Carrington manages phase 1, 2 and 3 clinical trials and is a dedicated researcher whose research is published in peer reviewed journals and has led to change in practice. She also holds a Doctorate in Clinical Pharmacy and a Masters in Medical Science in Clinical Oncology.
On presenting the award, SHPA President Professor Michael Dooley said, “Krissy certainly is a worthy recipient of this award as a recognised expert in cancer therapeutics and cancer pharmacy.
“She is highly regarded for her contribution to clinical pharmacy practice and the provision of services to patients with cancer. Her involvement in clinical pharmacy is as a clinician, researcher, educator and leader.
“On behalf of SHPA, I congratulate Krissy for her huge contribution to clinical pharmacy practice.”
Dr Carrington said it was a great honour to receive the award.
“I am very passionate about the key role the pharmacist has in the multidisciplinary cancer team and this award truly recognises that the cancer pharmacist really can make a difference to patient care,” she says.
“It also provides me with the opportunity to openly thank all those people who have supported and guided me though my career in cancer. I have been fortunate to have been inspired and influenced by some wonderful role models from both pharmacy and non-pharmacy backgrounds.”